Phase 2, Phase 3, Phase 4, page-25

I'd suggest it could be as soon as early next week considering there's an investor conference, need some 'fresh bait' to get 'big-fish' to part with big-money perse...

Wouldn't really expect VLA to 'show-off' old/dated data, especially if new 'indicative, open-label' data is available, it could just 2-3 'evaluable' patient-data sets that extend or maintain the 'performance-trends' thus far...

Just a hunch though, bring on the 10 Jan (9 Jan in US, NYC from memory)...

ML